linkedin

Message from the CEO

In just a decade, Samsung Biologics has rapidly evolved into the world’s largest and best-in-class CDMO service partner. We continue to expand our business scope to make the next leap in biopharma, and in this next decade, we will continue to build greater capabilities to meet new market demand as a top service innovator in the biopharmaceutical industry while ensuring quality and stable supply of life-saving drugs.

Since its launch, Samsung Biologics has not only expanded its manufacturing capacity but also established a solid track record of successful regulatory approvals and award-winning client satisfaction. In efforts to provide the highest level of customer-centric services, Samsung Biologics has implemented leading edge technologies and with great agility, demonstrated distinguished processes in terms of speed, price competitiveness, quality, and efficiency.

We are facing a time of significant challenges and market dynamics. To respond, we made bold moves by adding Plant 4 to the current site and purchasing additional land for Bio Campus II, as well as initiating our global expansion plan through the opening of our CDO R&D Center in San Francisco. We expect synergies from collaborations between the new global locations and our manufacturing sites in Songdo.

We embrace responsibility, expertise, and pride in our work, and will continue on our noble mission to enable improved accessibility of biomedicines and consequently the quality of life for people around the globe. We will challenge ourselves to improve in all facets of our business through innovation, dedication, and excellence so that we can continue to add meaningful value to all of our clients, partners, and shareholders.

Thank you for your continuous trust and support.

John Rim President & CEO

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Subscribe to our newsletter to download.
*If you have already subscribed, enter your email.

뉴스레터 구독 서비스 유무 확인
Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION

Copyright Samsung Biologics. All rights reserved